AU6580494A - Use of clioquinol for treating helicobacter, including (h. pylori), infections and related diseases - Google Patents

Use of clioquinol for treating helicobacter, including (h. pylori), infections and related diseases

Info

Publication number
AU6580494A
AU6580494A AU65804/94A AU6580494A AU6580494A AU 6580494 A AU6580494 A AU 6580494A AU 65804/94 A AU65804/94 A AU 65804/94A AU 6580494 A AU6580494 A AU 6580494A AU 6580494 A AU6580494 A AU 6580494A
Authority
AU
Australia
Prior art keywords
clioquinol
pylori
infections
related diseases
treating helicobacter
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU65804/94A
Inventor
Nicolaos Legakis
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
PN Gerolymatos SA
Original Assignee
PN Gerolymatos SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by PN Gerolymatos SA filed Critical PN Gerolymatos SA
Publication of AU6580494A publication Critical patent/AU6580494A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
AU65804/94A 1994-05-11 1994-05-11 Use of clioquinol for treating helicobacter, including (h. pylori), infections and related diseases Abandoned AU6580494A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IB1994/000104 WO1995031199A1 (en) 1994-05-11 1994-05-11 Use of clioquinol for treating helicobacter, including h. pylori, infections and related diseases

Publications (1)

Publication Number Publication Date
AU6580494A true AU6580494A (en) 1995-12-05

Family

ID=11004294

Family Applications (1)

Application Number Title Priority Date Filing Date
AU65804/94A Abandoned AU6580494A (en) 1994-05-11 1994-05-11 Use of clioquinol for treating helicobacter, including (h. pylori), infections and related diseases

Country Status (3)

Country Link
EP (1) EP0713392A1 (en)
AU (1) AU6580494A (en)
WO (1) WO1995031199A1 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT959888E (en) * 1996-08-13 2002-02-28 Gerolymatos P N Sa Use of the chelating agent CLIOQUINOL FOR THE MANUFACTURE OF A PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF ALZHEIMER'S DISEASE
US7045531B1 (en) 1997-03-11 2006-05-16 The General Hospital Corporation Composition comprising a metal chelator and a method of treating amyloidosis by administering the metal chelator
IL134263A (en) * 1997-08-21 2006-04-10 Gerolymatos P N Sa Pharmaceutical compositions containing phanquinone for the treatment of alzheimer's disease
US5980914A (en) * 1997-08-22 1999-11-09 P.N. Gerolymatos S.A. Clioquinol for the treatment of Parkinson's disease
US5994323A (en) * 1997-12-31 1999-11-30 P.N. Gerolymatos S.A. Pharmaceutical compositions comprising clioquinol in combination with vitamin B12 and therapeutic and prophylactic uses thereof
US6638711B1 (en) 1999-04-29 2003-10-28 The General Hospital Corporation Methods for identifying an agent that inhibits oxygen-dependent hydrogen peroxide formation activity but does not inhibit superoxide-dependent hydrogen peroxide formation
US6323218B1 (en) 1998-03-11 2001-11-27 The General Hospital Corporation Agents for use in the treatment of Alzheimer's disease
IN190017B (en) 1999-01-25 2003-05-31 Panacea Biotech Ltd
US6576625B2 (en) 2001-03-16 2003-06-10 Panacea Biotic Limited Targeted vesicular constructs for cytoprotection and treatment of H. pylori infections
US20060040980A1 (en) * 2004-08-20 2006-02-23 Lind Stuart E Ionophores as cancer chemotherapeutic agents
CN109675057B (en) * 2017-10-19 2023-02-21 北京泰德制药股份有限公司 Solid preparation containing pronase and preparation method thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3225367A1 (en) * 1982-07-07 1984-01-12 Hoechst Ag, 6230 Frankfurt MEDICINES FOR TREATING INFECTIOUS DIARRHOEEN
GB9010039D0 (en) * 1990-05-03 1990-06-27 Reckitt & Colmann Prod Ltd Medicament preparation
GB9108080D0 (en) * 1991-04-15 1991-06-05 Smithkline Beecham Plc Pharmaceutical composition

Also Published As

Publication number Publication date
WO1995031199A1 (en) 1995-11-23
EP0713392A1 (en) 1996-05-29

Similar Documents

Publication Publication Date Title
AU2187992A (en) Composition and method for disease treatment
AU6549898A (en) Method for the broad based treatment of infections, especially infections of organs such as the skin and vagina
AU6276194A (en) Use of monoterpenes, sesquiterpernes and diterpernes for the treatment of cancer
AU5362696A (en) Compounds and methods for the dectection of t. cruzi infection
AU4861493A (en) Clear leave-on treatment composition and method
AU2663097A (en) Compounds and methods for the selective treatment of cancer and bacterial infections
AU3541095A (en) Surgical face mask
AU4555097A (en) Compounds with antimycotic and cytostatic effect, preparation method, agent containing these compounds and dsm 11 092
AU1392900A (en) 2,5-diazabicyclo(2.2.1)heptane derivatives, their preparation and therapeutic uses
AU3607693A (en) Iris dilator, deformer and procedure
AU3636695A (en) Method, compositions, and apparatus for treating and preventing respiratory viral infections
AU1575697A (en) Compositions and methods for the treatment and diagnosis of cancer
AU7816694A (en) Method and system for the treatment of seeds and bulbs
AU6580494A (en) Use of clioquinol for treating helicobacter, including (h. pylori), infections and related diseases
AU3892593A (en) Composition for therapeutic or diagnostic use, process for its preparation and its use
AU1927495A (en) Vacuolating toxin-deficient (h. pylori) and related methods
AU3825995A (en) Blocking expression of virulence factors in s. aureus
AU2126495A (en) Recombinase-deficient (helicobacter pylori) and related methods
AU5922694A (en) 2-amino-4-quinolyl-dihydropyridines, processes for their preparation, and their use
GR3021203T3 (en) Process for the preparation of 1,1,1,2-tetrafluoro-2-chloroethan and pentafluorethane.
AU1630895A (en) Treatment of H. pylori infections
AU4994996A (en) Composition for the treatment of diarrhea, its use and its preparation
AU6701998A (en) Method for treatment of (h. pylori)
AU3896899A (en) Compositions for the treatment of tumors, and uses thereof
AU3322100A (en) Targeted vesicular constructs for cytoprotection and treatment of (h. pylori) infections